Trupanion (NASDAQ:TRUP) Issues Earnings Results

Trupanion (NASDAQ:TRUP) posted its earnings results on Wednesday. The financial services provider reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.09, Briefing.com reports. The firm had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. The company’s revenue was up 14.6% on a year-over-year basis. During the same quarter last year, the company earned ($0.10) earnings per share. Trupanion updated its Q4 2024 guidance to EPS and its FY 2024 guidance to EPS.

Trupanion Price Performance

TRUP stock traded up $1.87 during mid-day trading on Wednesday, hitting $55.12. 771,558 shares of the stock were exchanged, compared to its average volume of 680,043. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.63 and a quick ratio of 1.63. The stock has a market capitalization of $2.32 billion, a price-to-earnings ratio of -84.44 and a beta of 1.73. The business has a fifty day moving average price of $46.54 and a 200 day moving average price of $35.74. Trupanion has a 12 month low of $19.14 and a 12 month high of $55.74.

Wall Street Analysts Forecast Growth

TRUP has been the topic of a number of analyst reports. Stifel Nicolaus boosted their target price on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a report on Monday, September 23rd. Northland Securities raised their target price on Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a research note on Thursday, September 19th. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a report on Friday, August 9th. Piper Sandler raised their price target on shares of Trupanion from $38.00 to $45.00 and gave the company a “neutral” rating in a report on Wednesday, October 2nd. Finally, William Blair assumed coverage on shares of Trupanion in a report on Friday, July 19th. They issued an “outperform” rating on the stock. Four equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $41.83.

Insider Activity at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the transaction, the chief executive officer now directly owns 99,984 shares in the company, valued at $4,647,256.32. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CEO Margaret Tooth sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the transaction, the chief executive officer now directly owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Fawwad Qureshi sold 640 shares of the business’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $43.12, for a total value of $27,596.80. The disclosure for this sale can be found here. In the last three months, insiders have sold 8,764 shares of company stock valued at $405,238. Corporate insiders own 5.50% of the company’s stock.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.